STARTRK-2: A Basket Trial for Neuroendocrine Tumor Patients with Specific Gene Rearrangements
Precision medicine, molecular testing, basket studies, STARTRK-2 – it may sound like technology of the future but it is here today and it might be the answer to slowing or stopping tumor growth for neuroendocrine tumor (NET) patients who have specific…
READ MORE
Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.
PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST … READ MORE
Patient Education on Carcinoid Syndrome: From Diagnosis to Treatment
A Live Online Event on Wednesday, March 1, 11 am to 12 noon Eastern Standard Time
Ask Your Questions during the Live Program or Submit Them in Advance
Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient…
READ MORE
Neuroendocrine Tumors on TV: Rare Disease Day Special, February 28, 2017
NETs on TV! The Carcinoid Cancer Foundation has teamed up with The Balancing Act and Advanced Accelerator Applications to raise awareness about carcinoid and neuroendocrine tumors (NETs) during a feature on Lifetime TV on February 28 (Rare Disease…
READ MORE
April Luncheon with the Experts in White Plains, NY — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, April 2, 2017 at 12:00 pm at the Westchester Hills Golf Club, 401 Ridgeway Avenue, …
READ MORE
Call for Nominations: 7th Annual Warner Advocacy Award
Novartis Oncology and The NET Alliance have announced that nominations are open for the 7th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize the …
READ MORE
The Project Zebra Report: Real-World Insights from the Carcinoid and NET Patient Community
In honor of Worldwide NET Cancer Awareness Day, we are pleased to release the first ever Project Zebra Report: Real-World Insights from the Carcinoid and Neuroendocrine Tumor Patient Community, a collaboration between our partner Self Care Catalysts…
READ MORE
Fighting NET Cancer with Grace and Gratitude
The Carcinoid Cancer Foundation is very excited to share what we have planned around this year’s Worldwide NET Cancer Awareness Day, November 10, and hope you will help us spread the word about NET cancer to support and inspire one another, and those yet…
READ MORE
December Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Carcinoid and neuroendocrine tumor (NET) patients have a unique opportunity to hear from three medical experts during Lunch with the Experts in New York City on Sunday, December 18, 2016. This special program was initiated and is sponsored by the Big…
READ MORE
Go Zebra-Striped for NET Cancer Day
We’re incredibly excited to share our app worldwide to raise awareness of carcinoid and neuroendocrine cancers on and around NET Cancer Day, November 10, and throughout the year. Follow the directions here, https://www.carcinoid.org/go-zebra-striped/…
READ MORE
